Pharma Focus Asia

Richter-Helm Expands with the Construction of New Manufacturing Facility


Richter-Helm invests US$83 million to construct new biological manufacturing facility. The facility will be located at cGMP manufacturing facility in Bovenau, Germany.


The manufacturing facility will support the production of high value biopharmaceutical products.

The site covers an area of 10,000 m² and consists of all necessary utilities and infrastructure, such as QC-labs, warehouse and technical areas.

Currently, there are two cGMP-compliant production facilities with bioreactor capacities ranging up to 1,500 litres located in Hannover and Bovenau, Germany.

The facility will triple the size of the existing production capacity and increase its current warehouse, laboratory, and administration buildings.

The new manufacturing facility will add two additional highly flexible and fully equipped production trains with interchangeable product flows. In addition, bioreactor capacities of 300 litres and 1,500 litres will be added.

The new facility is expected to start its full-scale operations and manufacturing by the end of 2023.


TypeNew Construction
BudgetUS$83 million
Latest Issue
Get instant
access to our latest e-book
MFA + MMA 2024CPHI Chine || PMEC China 2024Asia Healthcare Week 2024Gibco Adherent Kidney Media PanelCPHI Korea 2024Equinix accelerated medical research...CHEMICAL INDONESIA 2024Thermofisher - Antibody Therapeutic PolishingINALAB 2024 Thermo Scientific - DynaDrive and DynaSpinDigital Health Asia 2024Rehab Expo 2024ISPE Singapore Affiliate Conference & Exhibition 20242024 PDA Pharmaceutical Manufacturing & Quality Conference2024 PDA Cell and Gene Pharmaceutical Products Conference 2024 PDA Aseptic Manufacturing Excellence Conference2024 PDA Aseptic Processing of Biopharmaceuticals ConferencePharma Quality Excellence Awards 20244th Annual Pharma GMP Quality Management 20243rd World ADC Asia 2024
Searching for an end-to-end patient tech solution?